<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2020-08-12" modified="2023-09-13" version="19" xmlns="http://uniprot.org/uniprot">
  <accession>J9ZXD8</accession>
  <name>PROT_BACS1</name>
  <protein>
    <recommendedName>
      <fullName evidence="2">Polytheonamide B</fullName>
    </recommendedName>
    <alternativeName>
      <fullName evidence="2">Proteusin</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name evidence="2" type="primary">poyA</name>
  </gene>
  <organism>
    <name type="scientific">Bacterium symbiont subsp. Theonella swinhoei (strain pTSMAC1)</name>
    <dbReference type="NCBI Taxonomy" id="1221190"/>
    <lineage>
      <taxon>Bacteria</taxon>
    </lineage>
  </organism>
  <reference evidence="4" key="1">
    <citation type="journal article" date="2012" name="Science" volume="338" first="387" last="390">
      <title>Metagenome mining reveals polytheonamides as posttranslationally modified ribosomal peptides.</title>
      <authorList>
        <person name="Freeman M.F."/>
        <person name="Gurgui C."/>
        <person name="Helf M.J."/>
        <person name="Morinaka B.I."/>
        <person name="Uria A.R."/>
        <person name="Oldham N.J."/>
        <person name="Sahl H.G."/>
        <person name="Matsunaga S."/>
        <person name="Piel J."/>
      </authorList>
      <dbReference type="PubMed" id="22983711"/>
      <dbReference type="DOI" id="10.1126/science.1226121"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <scope>EXPRESSION IN E.COLI</scope>
    <scope>D-AMINO ACID AT VAL-102; ALA-104; VAL-106; VAL-110; ASN-112; ASN-118; VAL-120; ASN-124; ASN-126; VAL-128; ASN-130; ASN-132; ASN-134; ASN-136; SER-138; ASN-140; ASN-142 AND THR-144</scope>
    <scope>METHYLATION AT ILE-99; VAL-101; VAL-102; VAL-103; VAL-105; VAL-106; VAL-110; ASN-112; THR-113; VAL-117; ASN-118; GLN-119; ASN-124; ASN-126; VAL-127; ASN-130; ASN-132; ASN-134; ASN-136 AND MET-141</scope>
    <scope>HYDROXYLATION AT VAL-120; ASN-126; VAL-128 AND ASN-134</scope>
  </reference>
  <comment type="function">
    <text evidence="1">Antimicrobial peptide active against Gram-positive bacteria (MIC=4-&gt;125 ug/ml) (PubMed:22983711). May act by forming transmembrane ion channels, since the peptide rapidly depolarizes the bacterial cytoplasmic membrane, simultaneously decreasing the membrane potential and intracellular potassium contents (PubMed:22983711).</text>
  </comment>
  <comment type="PTM">
    <text evidence="1">Epimerization of most, and perhaps all, L- to D-amino acids is catalyzed by PoyD, when PoyA and PoyD are coexpressed in E.coli.</text>
  </comment>
  <comment type="PTM">
    <text evidence="1">N-methylations are catalyzed by PoyE, when PoyA and PoyE are coexpressed in E.coli.</text>
  </comment>
  <comment type="PTM">
    <text evidence="1 3">To obtain 2-oxo-5,5-dimethylhexanoate, Thr-97 is firstly dehydrated by PoyF (PubMed:22983711). The second step possibly corresponds to methylation by PoyB/C, and the third step may be a cleavage by PoyH/J (Probable).</text>
  </comment>
  <comment type="miscellaneous">
    <text evidence="3">The name 'proteusin' is inspired by Proteus, a Greek shape-shifting sea god.</text>
  </comment>
  <comment type="miscellaneous">
    <text evidence="3">Compared to polytheonamide B, polytheonamide A has an additional sulfoxide moiety at Met-141, which arises from spontaneous oxidation during polytheonamide isolation.</text>
  </comment>
  <dbReference type="EMBL" id="JX456532">
    <property type="protein sequence ID" value="AFS60639.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="AlphaFoldDB" id="J9ZXD8"/>
  <dbReference type="TCDB" id="1.D.24.1.1">
    <property type="family name" value="the marine sponge polytheonamide b (ptb) family"/>
  </dbReference>
  <dbReference type="BioCyc" id="MetaCyc:MONOMER-124150"/>
  <dbReference type="GO" id="GO:0003824">
    <property type="term" value="F:catalytic activity"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="InterPro"/>
  </dbReference>
  <dbReference type="GO" id="GO:0046914">
    <property type="term" value="F:transition metal ion binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="InterPro"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042742">
    <property type="term" value="P:defense response to bacterium"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006807">
    <property type="term" value="P:nitrogen compound metabolic process"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="InterPro"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.90.330.10">
    <property type="entry name" value="Nitrile hydratase alpha /Thiocyanate hydrolase gamma"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR036648">
    <property type="entry name" value="CN_Hdrase_a/SCN_Hdrase_g_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR022513">
    <property type="entry name" value="TOMM_pelo"/>
  </dbReference>
  <dbReference type="NCBIfam" id="TIGR03793">
    <property type="entry name" value="leader_NHLP"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF56209">
    <property type="entry name" value="Nitrile hydratase alpha chain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0044">Antibiotic</keyword>
  <keyword id="KW-0929">Antimicrobial</keyword>
  <keyword id="KW-0208">D-amino acid</keyword>
  <keyword id="KW-0379">Hydroxylation</keyword>
  <keyword id="KW-0488">Methylation</keyword>
  <feature type="propeptide" id="PRO_0000450586" evidence="3">
    <location>
      <begin position="1"/>
      <end position="96"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000450587" description="Polytheonamide B" evidence="3">
    <location>
      <begin position="97"/>
      <end position="145"/>
    </location>
  </feature>
  <feature type="modified residue" description="2-oxo-5,5-dimethylhexanoate" evidence="1">
    <location>
      <position position="97"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-methylisoleucine" evidence="1">
    <location>
      <position position="99"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-methylvaline" evidence="1">
    <location>
      <position position="101"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-methyl-D-valine" evidence="1">
    <location>
      <position position="102"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-methylvaline" evidence="1">
    <location>
      <position position="103"/>
    </location>
  </feature>
  <feature type="modified residue" description="D-alanine (Ala)" evidence="1">
    <location>
      <position position="104"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-methylvaline" evidence="1">
    <location>
      <position position="105"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-methyl-D-valine" evidence="1">
    <location>
      <position position="106"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-methyl-D-valine" evidence="1">
    <location>
      <position position="110"/>
    </location>
  </feature>
  <feature type="modified residue" description="N4-methyl-D-asparagine" evidence="1">
    <location>
      <position position="112"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-hydroxyvaline (Thr)" evidence="1">
    <location>
      <position position="113"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-methylvaline" evidence="1">
    <location>
      <position position="117"/>
    </location>
  </feature>
  <feature type="modified residue" description="N4-methyl-D-asparagine" evidence="1">
    <location>
      <position position="118"/>
    </location>
  </feature>
  <feature type="modified residue" description="(3S)-3-methylglutamine" evidence="1">
    <location>
      <position position="119"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-hydroxy-D-valine" evidence="1">
    <location>
      <position position="120"/>
    </location>
  </feature>
  <feature type="modified residue" description="N4-methyl-D-asparagine" evidence="1">
    <location>
      <position position="124"/>
    </location>
  </feature>
  <feature type="modified residue" description="(3R)-N4-methyl-3-hydroxy-D-asparagine" evidence="1">
    <location>
      <position position="126"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-methylvaline" evidence="1">
    <location>
      <position position="127"/>
    </location>
  </feature>
  <feature type="modified residue" description="3-hydroxy-D-valine" evidence="1">
    <location>
      <position position="128"/>
    </location>
  </feature>
  <feature type="modified residue" description="N4-methyl-D-asparagine" evidence="1">
    <location>
      <position position="130"/>
    </location>
  </feature>
  <feature type="modified residue" description="N4-methyl-D-asparagine" evidence="1">
    <location>
      <position position="132"/>
    </location>
  </feature>
  <feature type="modified residue" description="(3R)-N4-methyl-3-hydroxy-D-asparagine" evidence="1">
    <location>
      <position position="134"/>
    </location>
  </feature>
  <feature type="modified residue" description="N4-methyl-D-asparagine" evidence="1">
    <location>
      <position position="136"/>
    </location>
  </feature>
  <feature type="modified residue" description="D-serine (Ser)" evidence="1">
    <location>
      <position position="138"/>
    </location>
  </feature>
  <feature type="modified residue" description="D-asparagine" evidence="1">
    <location>
      <position position="140"/>
    </location>
  </feature>
  <feature type="modified residue" description="3,3-dimethylmethionine" evidence="1">
    <location>
      <position position="141"/>
    </location>
  </feature>
  <feature type="modified residue" description="D-asparagine" evidence="1">
    <location>
      <position position="142"/>
    </location>
  </feature>
  <feature type="modified residue" description="D-threonine" evidence="1">
    <location>
      <position position="144"/>
    </location>
  </feature>
  <evidence type="ECO:0000269" key="1">
    <source>
      <dbReference type="PubMed" id="22983711"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="2">
    <source>
      <dbReference type="PubMed" id="22983711"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="3">
    <source>
      <dbReference type="PubMed" id="22983711"/>
    </source>
  </evidence>
  <evidence type="ECO:0000312" key="4">
    <source>
      <dbReference type="EMBL" id="AFS60639.1"/>
    </source>
  </evidence>
  <sequence length="145" mass="15425" checksum="A01FD18DAF5944EE" modified="2012-11-28" version="1" precursor="true">MADSDNTPTSRKDFETAIIAKAWKDPEYLRRLRSNPREVLQEELEALHPGAQLPDDLGISIHEEDENHVHLVMPRHPQNVSDQTLTDDDLDQAAGGTGIGVVVAVVAGAVANTGAGVNQVAGGNINVVGNINVNANVSVNMNQTT</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>